McGill University: Generic semaglutide could reshape diabetes drug coverage in Canada
August 19, 2026
August 19, 2026
MONTREAL, Quebec, Aug. 19 -- McGill University posted the following news release:
* * *
Generic semaglutide could reshape diabetes drug coverage in Canada
*
The arrival of generic semaglutide in Canada significantly improves the cost-effectiveness and affordability of recommended treatments for up to 2.1 million Canadians living with Type 2 diabetes who face a high risk of cardiovascular disease, according to a simulation study led by researche . . .
* * *
Generic semaglutide could reshape diabetes drug coverage in Canada
*
The arrival of generic semaglutide in Canada significantly improves the cost-effectiveness and affordability of recommended treatments for up to 2.1 million Canadians living with Type 2 diabetes who face a high risk of cardiovascular disease, according to a simulation study led by researche . . .